When was SAMDI Tech founded?

SAMDI Tech was founded in 2011 and raised its 1st funding round within a year of its incorporation.

Where is SAMDI Tech located?

SAMDI Tech is headquartered in Chicago, United States. It is registered at Chicago, Illinois.

How many employees does SAMDI Tech have?

As of Jun 30, 2026, the latest employee count at SAMDI Tech is 6.

Is SAMDI Tech a funded company?

SAMDI Tech is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 08, 2011.

When was the latest funding round of SAMDI Tech?

SAMDI Tech's latest funding was a $***** Grant (prize money) round on Jul 10, 2020, with participation from 1 investor.

Where does SAMDI Tech rank among its competitors?

SAMDI Tech ranks 11th amongst 52 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Phoremost, which secured $12M in Sep, 2024.

Who are the top competitors of SAMDI Tech?

SAMDI Tech's top competitors include Molcure, Phoremost and Modular Genetics. Among them, Phoremost secured the most recent funding round in September, 2024.

SAMDI Tech - 2026 Company Profile, Funding & Competitors

Company Details

SAMDI Tech is a biotech company developing a platform for high-throughput screening that combines MALDI-TOF mass spectrometry with high-density arrays for rapid, quantitative measurements of analytes in biochemical reactions. The arrays are manufactured in 384 or 1536 formats and are compatible with standard laboratory automation systems. Each spot on the array uses a thin layer of gold with a self-assembled monolayer for controlled analyte capture. The company offers assay development services (assay transfer to the SAMDI format, Km determination, [Enz] vs Velocity, IC50 determination, DMSO tolerance, etc), and a range of standardized in vitro assays (methyltransferases, demethylases, acetyltransferases, kinases, phosphatases, deiminases, ubiquitin ligases, deubiquitinases, proteases, ligases, glycosyltransferases, glycosidases, acyltransferases, polymerases, etc). SAMDI Tech also has a library of 350,000 small molecule compounds that it offers for HTS screens.

Website: samditech.com
Social
Registered Address: Chicago, Illinois

Key Metrics

Founded Year

2011

Location

Chicago, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Jul 10, 2020, $*****

Investors

National Science Foundation & 1 more

Ranked

11^th among 52 active competitors

Employee Count

6 as on Jun 30, 2026

Similar Companies

Molcure & 64 more

Exit Details

Acquired by Charles River Laboratories (Jan 30, 2023)

View SAMDI Tech's full profile

SAMDI Tech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SAMDI TECH, INC. CIN: 272235112 , United States, Active	Dec 26, 999	-	8 (As on Dec 31, 2022)	-

SAMDI Tech got acquired by Charles River Laboratories on Jan 30, 2023 at an acquisition amount of $*****.

Click here to take a look at SAMDI Tech's acquisition in detail

SAMDI Tech has raised funding over 4 rounds. Its first funding round was on Jun 08, 2011. Its latest funding round was a Grant (prize money) round on Jul 10, 2020 for $*****. 1 investor participated in its latest round. SAMDI Tech has 2 institutional investors.

Here is the list of recent funding rounds of SAMDI Tech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 10, 2020	4001160	Grant (prize money)	2468014	6407211	2954305	1964809
Aug 21, 2019	7002652	Grant (prize money)	7412215	3968431	2369614	HHS
Jul 01, 2011	5942266	Grant (prize money)	8759629	4097765	7743498	HHS

Access funding benchmarks and valuations. Sign up today!

View details of SAMDI Tech's funding rounds and investors

SAMDI Tech's employee count trend

SAMDI Tech has 6 employees as of Jun 26. Here is SAMDI Tech's employee count trend over the years:

Uncover SAMDI Tech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SAMDI Tech include Molcure, Phoremost and Modular Genetics. Here is the list of Top 10 competitors of SAMDI Tech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Molcure 2013, Tokyo (Japan), Series C	Provider of AI-based platform for drug discovery and design	$11.7M	JAFCO Group, Dai-Ichi Life & 7 others	53/100
2nd	Phoremost 2015, Cambridge (United Kingdom), Series B	Developer of a phenotypic screening platform for drug target discovery	$76.8M	Parkwalk, Amadeus Capital & 13 others	52/100
3rd	Modular Genetics 2000, Woburn (United States), Series B	Developer of a proprietary, automated system for gene engineering and molecular biology	$8.9M	National Science Foundation, America’s Seed Fund ... & 2 others	52/100
4th	Adaptyv Biosystems 2021, Lausanne (Switzerland), Seed	Provider of protein design, synthesis, testing, and validation services	$2.62M	Y Combinator, Founderful & 12 others	51/100
5th	64x Bio 2017, San Francisco (United States), Series A	Developer of cell lines and production technologies for advanced therapies	$59.6M	First Round Capital, Fifty Years & 13 others	49/100
6th	Rheonix 2008, Ithaca (United States), Series B	Provider of instruments for automated assays	$72.7M	Rand Capital, Cayuga Venture Fund & 11 others	45/100
7th	reMYND 2002, Leuven (Belgium), Series B	Developer of a drug pipeline programs for neurodegenerative diseases	$29.1M	Korys, SFPI & 6 others	43/100
8th	AimedBio 2018, Seoul (South Korea), Public	Developer of screening platform for brain drug discovery and efficacy	-	Samsung Life Science	43/100
9th	Beacon Discovery 2016, San Diego (United States), Acquired	Develops assay platforms to identify GPCR based therapeutics	-	-	39/100
10th	Nanna Therapeutics 2012, Cambridge (United Kingdom), Acquired	Provider of in-vitro directed evolution platform for drug discovery	-	New Wave Ventures, Gov & 1 others	37/100
11th	SAMDI Tech 2011, Chicago (United States), Acquired	Proprietary high-throughput MALDI-TOF platform for HTS services	-	National Science Foundation, HHS	36/100